Phospholipase A2 receptor antibodies in membranous nephropathy: Unresolved issues

Journal of the American Society of Nephrology

Volumn 25, Issue 6, 2014, Pages 1137-1139

  Hofstra, Julia M ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; PHOSPHOLIPASE A2 RECEPTOR; PLA2R1 PROTEIN, HUMAN;

HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; TREATMENT DURATION; APLA2R; FEMALE; IMMUNOLOGY; MALE; NOTE; PROTEINURIA;

APLA2R; MEMBRANOUS NEPHROPATHY;

AUTOANTIBODIES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; PROTEINURIA; RECEPTORS, PHOSPHOLIPASE A2;

EID: 84906074841     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014010091     Document Type: Review

References (24)

1. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
2. Hofstra JM, Wetzels JF: Anti-PLA2R antibodies in membranous nephropathy: Ready for routine clinical practice? Neth J Med 70: 109-113, 2012
3. DebiecH, Ronco P:Nephrotic syndrome:Anewspecific test for idiopathic membranous nephropathy. Nat Rev Nephrol 7: 496-498, 2011
4. Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA: Enhanced expression of the M-type phospholipaseA2 receptor in glomeruli correlateswith serumreceptor antibodies in primary membranous nephropathy. Kidney Int 82: 797-804, 2012
5. HofstraJM,Beck LHJr,BeckDM,Wetzels JF,SalantDJ:Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286-1291, 2011
6. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG, Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ: Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22: 1543-1550, 2011
7. Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R,Mathieson PW, Ronco P, Brenchley PE, Wetzels JF: Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23: 1735-1743, 2012
8. HoxhaE, Thiele I, ZahnerG, PanzerU,HarendzaS, StahlRAK:Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 25: 1357-1366, 2014
9. Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W: Developmentof a standardizedELISAfor thedetermination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 421: 213-218, 2013
10. Beck LH Jr, Salant DJ: Membranous nephropathy: Recent travels and new roads ahead. Kidney Int 77: 765-770, 2010
11. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Antiphospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22: 1137-1143, 2011
12. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA: An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26: 2526-2532, 2011
13. Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS: Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy. PLoS ONE 8: e62151, 2013
14. Murtas C, Bruschi M, Candiano G, Moroni G,Magistroni R,Magnano A, Bruno F, Radice A, Furci L, Argentiero L, CarnevaliML,Messa P, Scolari F, Sinico RA, Gesualdo L, Fervenza FC, Allegri L, Ravani P, Ghiggeri GM: Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 7: 1394-1400, 2012
15. Kanigicherla D, Gummadova J, McKenzie EA, Roberts SA, Harris S, NikamM, Poulton K,McWilliam L, Short CD, VenningM, Brenchley PE: Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 83: 940-948, 2013
16. Gunnarsson I, Schlumberger W, Rönnelid J: Antibodies to M-type phospholipase A2 receptor (PLA2R) and membranous lupus nephritis. Am J Kidney Dis 59: 585-586, 2012
17. Svobodova B, Honsova E, Ronco P, Tesar V, Debiec H: Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant 28: 1839-1844, 2013
18. Knehtl M, Debiec H, Kamgang P, Callard P, Cadranel J, Ronco P, Boffa JJ: A case of phospholipase A2 receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. AmJ Kidney Dis 57: 140-143, 2011
19. Huang X, Qin W, Zhang M, Zheng C, Zeng C, Liu Z: Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stemcell transplantation membranous nephropathy. Am JMed Sci 346: 32-37, 2013
20. Ronco P, Debiec H: Pathogenesis of membranous nephropathy: Recent advances and future challenges. Nat Rev Nephrol 8: 203-213, 2012
21. Debiec H, Hanoy M, Francois A, Guerrot D, Ferlicot S, Johanet C, Aucouturier P,GodinM, Ronco P: Recurrent membranous nephropathy in an allograft caused by IgG3k targeting the PLA2 receptor. J AmSoc Nephrol 23: 1949-1954, 2012
22. Hofstra JM, Bech AP, Brenchley PE, Wetzels JF: Measurement of anti-PLA2R antibodies predicts relapse rate after immunosuppressive therapy in patients with idiopathic membranous nephropathy [Abstract FR-OR049]. J Am Soc Nephrol 24: 47A, 2013
23. Debiec H, Ronco P: PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl JMed 364: 689-690, 2011
24. Larsen CP,Messias NC, Silva FG,Messias E,Walker PD: Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol 26: 709-715, 2013